Search
forResearch 10 of 1000+
- Causal effects of genetically determined metabolites on androgenetic alopecia: A two‐sample Mendelian randomization analysis
- Autoimmune thyroid disease and human health: a systematic review of Mendelian randomization studies
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions
- Genetically determined metabolites in allergic conjunctivitis: A Mendelian randomization study
- A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men
- A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss
- Effects of in vivo-administered 2,3,7,8-tetrachlorodibenzo-p-dioxin on receptor binding of epidermal growth factor in the hepatic plasma membrane of rat, guinea pig, mouse, and hamster.
- Roles of p38- and c-jun NH2-terminal kinase-mediated pathways in 2-methoxyestradiol-induced p53 induction and apoptosis
- 2-Substituted 4-(Thio)chromenone 6-<i>O</i>-Sulfamates: Potent Inhibitors of Human Steroid Sulfatase
- A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women
Community 10 of 1000+
- 2 years on 0.5mg dutasteride, 5mg oral minoxidil
- 2 months of progress on topical minoxidil
- 2 years of Dut and Oral Min. Still room for improvement?
- 2 months update: Topical Minoxidil
- 2 months on 1mg Fin and 3mg Minoxodil
- 2 year update: 1.2mg Fin, 3mg Min
- 2 months only Topical Minoxidil progress
- 2 years apart. 0.5mg Dut, 2.5mg oral minox. HT at 1.2 years ; Age 26->28
- 2 years on dutasteride: My experience so far
- 2 months on oral fin... vellus hairs!